0001179110-14-009796.txt : 20140623 0001179110-14-009796.hdr.sgml : 20140623 20140604200444 ACCESSION NUMBER: 0001179110-14-009796 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140602 FILED AS OF DATE: 20140604 DATE AS OF CHANGE: 20140604 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERAVANCE INC CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508086000 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tyree James L CENTRAL INDEX KEY: 0001324991 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 14892296 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-6400 4 1 edgar.xml FORM 4 - X0306 4 2014-06-02 0 0001080014 THERAVANCE INC THRX 0001324991 Tyree James L THERAVANCE, INC. 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2014-06-02 4 A 0 6000 0 A 6000 D Common Stock 2014-06-02 4 A 0 6000 0 A 12000 D Stock Option (Right to Buy) 23.0786 2014-06-02 4 A 0 6000 0 A 2024-06-01 Common Stock 6000 6000 D Stock Option (Right to Buy) 23.0786 2014-06-02 4 A 0 6000 0 A 2024-06-01 Common Stock 6000 6000 D The number of shares will be adjusted by a factor that is not determinable at the time of this filing to account for the effect of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc. This option may be exercised and shall be vested as to 1/24th of the shares subject to this option when optionee completes each continuous month of service following the grant date. This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's stockholders provided the optionee remains in continuous service on such date. Bradford J. Shafer, Attorney-in-Fact 2014-06-04